Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 637853, 8 pages
http://dx.doi.org/10.1155/2015/637853
Research Article

The Expression and Correlation of iNOS and p53 in Oral Squamous Cell Carcinoma

1The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan 430079, China
2Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Guangzhou 510140, China
3The Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510120, China

Received 27 November 2014; Revised 22 January 2015; Accepted 22 January 2015

Academic Editor: Maria Lina Tornesello

Copyright © 2015 Lan Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. H. H. W. Schmidt and U. Walter, “NO at work,” Cell, vol. 78, no. 6, pp. 919–925, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Xu, L. Z. Liu, M. Loizidou, M. Ahmed, and I. G. Charles, “The role of nitric oxide in cancer,” Cell Research, vol. 12, no. 5-6, pp. 311–320, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. S. K. Choudhari, M. Chaudhary, S. Bagde, A. R. Gadbail, and V. Joshi, “Nitric oxide and cancer: a review,” World Journal of Surgical Oncology, vol. 11, article 118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Lechner, P. Lirk, and J. Rieder, “Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin,” Seminars in Cancer Biology, vol. 15, no. 4, pp. 277–289, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. P. A. Brennan, S. Dennis, D. Poller, M. Quintero, R. Puxeddu, and G. J. Thomas, “Inducible nitric oxide synthase: correlation with extracapsular spread and enhancement of tumor cell invasion in head and neck squamous cell carcinoma,” Head & Neck, vol. 30, no. 2, pp. 208–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Vakkala, K. Kahlos, E. Lakari, P. Pääkkö, V. Kinnula, and Y. Soini, “Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas,” Clinical Cancer Research, vol. 6, no. 6, pp. 2408–2416, 2000. View at Google Scholar · View at Scopus
  7. P. A. Brennan, S. Sharma, J. R. Bowden, and T. Umar, “Expression of inducible nitric oxide sythase in bone metastases,” European Journal of Surgical Oncology, vol. 29, no. 7, pp. 619–623, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Broholm, I. Rubin, A. Kruse et al., “Nitric oxide synthase expression and enzymatic activity in human brain tumors,” Clinical Neuropathology, vol. 22, no. 6, pp. 273–281, 2003. View at Google Scholar · View at Scopus
  9. L. Speranza, M. A. De Lutiis, Y. B. Shaik et al., “Localization and activity of iNOS in normal human lung tissue and lung cancer tissue,” International Journal of Biological Markers, vol. 22, no. 3, pp. 226–231, 2007. View at Google Scholar · View at Scopus
  10. S. T. Connelly, M. Macabeo-Ong, N. Dekker, R. C. K. Jordan, and B. L. Schmidt, “Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma,” Oral Oncology, vol. 41, no. 3, pp. 261–267, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Sappayatosok, Y. Maneerat, S. Swasdison et al., “Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 14, no. 7, pp. E319–E324, 2009. View at Google Scholar · View at Scopus
  12. W.-L. Chen, S.-G. Zeng, H.-G. Li, H.-Z. Huang, and C.-B. Pan, “Expression of inducible nitric oxide synthase mRNA in squamous cell carcinoma of tongue,” Ai Zheng, vol. 21, no. 3, pp. 314–318, 2002. View at Google Scholar · View at Scopus
  13. L. E. Giono and J. J. Manfredi, “The p53 tumor suppressor participates in multiple cell cycle checkpoints,” Journal of Cellular Physiology, vol. 209, no. 1, pp. 13–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. K. T. Bieging, S. S. Mello, and L. D. Attardi, “Unravelling mechanisms of p53-mediated tumour suppression,” Nature Reviews Cancer, vol. 14, no. 5, pp. 359–370, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. W. E. Mercer, “Cell cycle regulation and the p53 tumor suppressor protein,” Critical Reviews in Eukaryotic Gene Expression, vol. 2, no. 3, pp. 251–263, 1992. View at Google Scholar · View at Scopus
  16. L. Weisz, A. Damalas, M. Liontos et al., “Mutant p53 enhances nuclear factor κB activation by tumor necrosis factor α in cancer cells,” Cancer Research, vol. 67, no. 6, pp. 2396–2401, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Zalcenstein, L. Weisz, P. Stambolsky, J. Bar, V. Rotter, and M. Oren, “Repression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53,” Oncogene, vol. 25, no. 3, pp. 359–369, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. D. P. Liu, H. Song, and Y. Xu, “A common gain of function of p53 cancer mutants in inducing genetic instability,” Oncogene, vol. 29, no. 7, pp. 949–956, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Strano, S. Dell'Orso, S. Di Agostino, G. Fontemaggi, A. Sacchi, and G. Blandino, “Mutant p53: an oncogenic transcription factor,” Oncogene, vol. 26, no. 15, pp. 2212–2219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Leroy, L. Girard, A. Hollestelle, J. D. Minna, A. F. Gazdar, and T. Soussi, “Analysis of TP53 mutation status in human cancer cell lines: a reassessment,” Human Mutation, vol. 35, no. 6, pp. 756–765, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Gochman, J. Mahajna, P. Shenzer et al., “The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans,” Acta Histochemica, vol. 114, no. 8, pp. 827–835, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Strano, S. Dell'Orso, A. M. Mongiovi et al., “Mutant p53 proteins: between loss and gain of function,” Head and Neck, vol. 29, no. 5, pp. 488–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. A. C. Abrahao, B. V. Bonelli, F. D. Nunes, E. P. Dias, and M. G. Cabral, “Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders,” Brazilian Oral Research, vol. 25, no. 1, pp. 34–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Gasco and T. Crook, “The p53 network in head and neck cancer,” Oral Oncology, vol. 39, no. 3, pp. 222–231, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. L. R. de Oliveira, A. Ribeiro-Silva, and S. Zucoloto, “Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma,” Journal of Oral Pathology and Medicine, vol. 36, no. 4, pp. 191–197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. C. Abrahao, B. V. Bonelli, F. D. Nunes, E. P. Dias, and M. G. Cabral, “Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders,” Brazilian Oral Research, vol. 25, no. 1, pp. 34–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Oridate, A. Homma, E. Higuchi et al., “p53 expression in concurrent chemoradiotherapy with docetaxel for head and neck squamous cell carcinoma,” Auris Nasus Larynx, vol. 36, no. 1, pp. 57–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Moon, K. Y. Won, J. Y. Lee, I. Kang, and S.-K. Lee, “Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix,” Pathology, vol. 43, no. 5, pp. 453–458, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. D. W. Davis, D. A. Weidner, A. Holian, and D. J. McConkey, “Nitric oxide-dependent activation of p53 suppresses bleomycin-induced apoptosis in the lung,” Journal of Experimental Medicine, vol. 192, no. 6, pp. 857–869, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Matsumoto, M. Furihata, A. Kurabayashi, K. Araki, S. Sasaguri, and Y. Ohtsuki, “Association between inducible nitric oxide synthase expression and p53 status in human esophageal squamous cell carcinoma,” Oncology, vol. 64, no. 1, pp. 90–96, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Kostourou, J. E. Cartwright, A. P. Johnstone et al., “The role of tumour-derived iNOS in tumour progression and angiogenesis,” British Journal of Cancer, vol. 104, no. 1, pp. 83–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. L. L. Ma, W. J. Sun, Z. Wang, G. Y. Zh, P. Li, and S. B. Fu, “Effects of silencing of mutant p53 gene in human lung adenocarcinoma cell line Anip973,” Journal of Experimental and Clinical Cancer Research, vol. 25, no. 4, pp. 585–592, 2006. View at Google Scholar · View at Scopus